Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 10 01:32PM ET
10.78
Dollar change
-0.21
Percentage change
-1.95
%
IndexRUT P/E- EPS (ttm)-2.30 Insider Own16.00% Shs Outstand56.43M Perf Week-4.72%
Market Cap608.09M Forward P/E- EPS next Y-1.77 Insider Trans0.00% Shs Float47.40M Perf Month1.37%
Income-93.24M PEG- EPS next Q-0.42 Inst Own83.41% Short Float7.32% Perf Quarter-5.97%
Sales0.00M P/S- EPS this Y30.36% Inst Trans-5.62% Short Ratio9.10 Perf Half Y-4.30%
Book/sh4.58 P/B2.35 EPS next Y-5.22% ROA-32.43% Short Interest3.47M Perf Year60.84%
Cash/sh6.29 P/C1.71 EPS next 5Y- ROE-34.06% 52W Range4.26 - 16.90 Perf YTD40.31%
Dividend Est.- P/FCF- EPS past 5Y39.84% ROI-26.52% 52W High-36.24% Beta0.72
Dividend TTM- Quick Ratio21.87 Sales past 5Y0.00% Gross Margin- 52W Low152.96% ATR (14)0.67
Dividend Ex-DateMar 29, 2005 Current Ratio21.87 EPS Y/Y TTM5.76% Oper. Margin0.00% RSI (14)43.45 Volatility4.75% 6.28%
Employees59 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price25.14
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q4.57% Payout- Rel Volume0.16 Prev Close10.99
Sales Surprise- EPS Surprise-16.75% Sales Q/Q- EarningsAug 12 AMC Avg Volume380.96K Price10.78
SMA20-6.28% SMA50-4.25% SMA200-2.40% Trades Volume38,213 Change-1.95%
Date Action Analyst Rating Change Price Target Change
Jul-29-24Initiated TD Cowen Buy $35
Mar-28-23Initiated Evercore ISI Outperform $18
Oct-02-24 04:10PM
Sep-30-24 08:00AM
Sep-27-24 08:00AM
Sep-19-24 08:00AM
Sep-04-24 04:10PM
08:00AM Loading…
Aug-30-24 08:00AM
Aug-29-24 08:00AM
Aug-12-24 04:10PM
04:00PM
Aug-07-24 08:00AM
Aug-02-24 04:10PM
Jul-02-24 04:10PM
Jun-04-24 04:10PM
May-30-24 08:00AM
May-24-24 08:00AM
08:00AM Loading…
May-23-24 08:00AM
May-09-24 04:10PM
May-08-24 08:00AM
May-02-24 04:00PM
Apr-09-24 08:00AM
Apr-03-24 07:00PM
04:10PM
Mar-25-24 07:30AM
Mar-05-24 04:10PM
Mar-04-24 10:52PM
04:10PM
Feb-29-24 03:02AM
Feb-20-24 08:00AM
Feb-06-24 08:00AM
Feb-05-24 04:00PM
07:29PM Loading…
Jan-30-24 07:29PM
09:08AM
Dec-04-23 04:00PM
Nov-27-23 08:00AM
Nov-21-23 08:00AM
Nov-14-23 01:07PM
Nov-13-23 11:07AM
08:00AM
Nov-10-23 08:00AM
Nov-09-23 08:00AM
Nov-03-23 08:10AM
Nov-02-23 04:00PM
Oct-30-23 08:00AM
Oct-11-23 07:14PM
05:10PM
Oct-03-23 04:00PM
Sep-06-23 08:00AM
Aug-31-23 08:00AM
Aug-30-23 10:01AM
Aug-25-23 08:00AM
Aug-07-23 04:10PM
Aug-02-23 04:00PM
Jul-20-23 08:00AM
Jul-17-23 08:00AM
Jul-14-23 08:00AM
Jul-06-23 04:00PM
Jun-06-23 08:00AM
Jun-05-23 08:00AM
May-31-23 08:00AM
May-11-23 04:10PM
May-02-23 04:00PM
Apr-28-23 08:00AM
Apr-19-23 08:00AM
Apr-04-23 04:00PM
Mar-22-23 08:00AM
Mar-08-23 08:00AM
Mar-06-23 08:00AM
Mar-02-23 04:00PM
Feb-24-23 08:00AM
Feb-21-23 08:00AM
Feb-08-23 08:00AM
Feb-02-23 04:00PM
Dec-19-22 04:01PM
Dec-15-22 06:10AM
06:00AM
Dec-02-22 04:00PM
Nov-10-22 04:10PM
Nov-09-22 08:00AM
Nov-07-22 08:00AM
Nov-02-22 08:00AM
Sep-16-22 08:00AM
Sep-06-22 08:00AM
Sep-02-22 08:00AM
Aug-09-22 04:32PM
Aug-04-22 08:00AM
Aug-03-22 08:00AM
Aug-02-22 08:00AM
Jul-29-22 09:34AM
Jul-28-22 08:00AM
Jul-15-22 08:00AM
Jul-14-22 08:00AM
Jul-05-22 08:00AM
Jun-23-22 08:00AM
Jun-03-22 08:00AM
Jun-02-22 08:00AM
May-12-22 04:10PM
Apr-21-22 08:00AM
Apr-04-22 08:00AM
Mar-10-22 05:01PM
Mar-09-22 08:00AM
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morabito ChristopherChief Medical OfficerApr 01 '24Option Exercise3.8710,00038,70010,000Apr 03 04:05 PM
Morabito ChristopherChief Medical OfficerApr 01 '24Sale13.5910,000135,9390Apr 03 04:05 PM
PERCEPTIVE ADVISORS LLCDirectorFeb 01 '24Buy12.092,481,35029,999,5224,873,721Feb 05 05:02 PM
Morabito ChristopherChief Medical OfficerJan 29 '24Option Exercise3.879,20035,6049,200Jan 30 05:03 PM
Morabito ChristopherChief Medical OfficerJan 26 '24Option Exercise3.878003,096800Jan 30 05:03 PM
Morabito ChristopherChief Medical OfficerJan 29 '24Sale11.159,200102,5520Jan 30 05:03 PM
Morabito ChristopherChief Medical OfficerJan 26 '24Sale11.028008,8120Jan 30 05:03 PM
PERCEPTIVE ADVISORS LLCDirectorDec 21 '23Buy6.20740,0004,588,0002,392,371Dec 22 02:51 PM
PERCEPTIVE ADVISORS LLCDirectorOct 16 '23Buy6.511,074,6086,999,9971,652,371Oct 18 04:11 PM